• 77968 Citations
  • 135 h-Index
1989 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Jorge Eduardo Cortes is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.



Cortes, J. E., Kurzrock, R., Ming-Sheng, L., Reading, C., Emerson, S., Liang, J., Deisseroth, A., Feinberg, A., Siciliano, M., Kantarjian, H., Talpaz, M., Andreeff, M., Kornblau, S., Thall, P., Issa, J. P., Estrov, Z., Arlinghaus, R. B., Deininger, M., Champlin, R., Shpall, E., Austin, D., Claxton, D., Belmont, J., Reisner, Y. & Issa, K.

National Institutes of Health

Project: Research project

  • Research Output

    A heavy metal baseline score predicts outcome in acute myeloid leukemia

    Ohanian, M., Telouk, P., Kornblau, S., Albarede, F., Ruvolo, P., Tidwell, R. S. S., Plesa, A., Kanagal-Shamanna, R., Matera, E. L., Cortes, J., Carson, A. & Dumontet, C., 2020, (Accepted/In press) In : American Journal of Hematology.

    Research output: Contribution to journalArticle

  • Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype

    Samra, B., Richard-Carpentier, G., Kadia, T. M., Ravandi, F., Daver, N., DiNardo, C. D., Issa, G. C., Bose, P., Konopleva, M. Y., Yilmaz, M., Ohanian, M., Borthakur, G., Garcia-Manero, G., Pierce, S., Cortes, J. E., Kantarjian, H. & Short, N. J., May 1 2020, In : Blood Cancer Journal. 10, 5, 47.

    Research output: Contribution to journalArticle

    Open Access
  • Clinical value of event-free survival in acute myeloid leukemia

    Maiti, A., Kantarjian, H. M., Popat, V., Borthakur, G., Garcia-Manero, G., Konopleva, M. Y., DiNardo, C. D., Verstovsek, S., Andreeff, M., Kadia, T. M., Ajufo, H. O., Goswamy, R. V., Blanco, C., Velasquez, M., Daver, N. G., Pemmaraju, N., Pierce, S. R., Wierda, W. G., Kornblau, S. M., Ravandi, F. & 1 others, Cortes, J. E., Apr 28 2020, In : Blood Advances. 4, 8, p. 1690-1699 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • Consolidation outcomes in CPX-351 versus cytarabine/daunorubicin-treated older patients with high-risk/secondary acute myeloid leukemia

    Kolitz, J. E., Strickland, S. A., Cortes, J. E., Hogge, D., Lancet, J. E., Goldberg, S. L., Villa, K. F., Ryan, R. J., Chiarella, M., Louie, A. C., Ritchie, E. K. & Stuart, R. K., Feb 23 2020, In : Leukemia and Lymphoma. 61, 3, p. 631-640 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN randomized study

    Cortes, J. E., Jiang, Q., Wang, J., Weng, J., Zhu, H., Liu, X., Hochhaus, A., Kim, D. W., Radich, J., Savona, M., Martin-Regueira, P., Sy, O., Gurnani, R. & Saglio, G., Aug 1 2020, In : Leukemia. 34, 8, p. 2064-2073 10 p.

    Research output: Contribution to journalArticle

    Open Access